|
gptkbp:instanceOf
|
gptkb:abbreviation
|
|
gptkbp:alternativeName
|
gptkb:the_pill
|
|
gptkbp:canBe
|
emergency contraception (in some regimens)
|
|
gptkbp:contains
|
gptkb:estrogen
gptkb:progestin
|
|
gptkbp:contraindication
|
gptkb:cancer
gptkb:liver_disease
history of thromboembolic disorders
|
|
gptkbp:effect
|
about 91% with typical use
over 99% with perfect use
|
|
gptkbp:introducedIn
|
1960
|
|
gptkbp:manufacturer
|
various pharmaceutical companies
|
|
gptkbp:mayIncreaseRiskOf
|
breast cancer (slightly)
|
|
gptkbp:notProtectAgainst
|
sexually transmitted infections
|
|
gptkbp:prescriptionRequired
|
true
|
|
gptkbp:reduces
|
gptkb:cancer
gptkb:endometrial_cancer
|
|
gptkbp:regimen
|
21 days active, 7 days placebo
28 days continuous
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
headache
increased risk of blood clots
|
|
gptkbp:standsFor
|
oral contraceptive pills
|
|
gptkbp:usedFor
|
birth control
treatment of acne
regulation of menstrual cycles
|
|
gptkbp:bfsParent
|
gptkb:OCP_uniform
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
OCPs
|